278 related articles for article (PubMed ID: 29268706)
1. N-glycosylation of serum proteins for the assessment of patients with IgD multiple myeloma.
Chen J; Fang M; Chen X; Yi C; Ji J; Cheng C; Wang M; Gu X; Sun Q; Gao C
BMC Cancer; 2017 Dec; 17(1):881. PubMed ID: 29268706
[TBL] [Abstract][Full Text] [Related]
2. Serum N-Glycans: A New Diagnostic Biomarker for Light Chain Multiple Myeloma.
Chen J; Fang M; Zhao YP; Yi CH; Ji J; Cheng C; Wang MM; Gu X; Sun QS; Chen XL; Gao CF
PLoS One; 2015; 10(6):e0127022. PubMed ID: 26075387
[TBL] [Abstract][Full Text] [Related]
3. N-glycomic changes in serum proteins in type 2 diabetes mellitus correlate with complications and with metabolic syndrome parameters.
Testa R; Vanhooren V; Bonfigli AR; Boemi M; Olivieri F; Ceriello A; Genovese S; Spazzafumo L; Borelli V; Bacalini MG; Salvioli S; Garagnani P; Dewaele S; Libert C; Franceschi C
PLoS One; 2015; 10(3):e0119983. PubMed ID: 25793407
[TBL] [Abstract][Full Text] [Related]
4. Serum protein N-glycosylation changes in multiple myeloma.
Zhang Z; Westhrin M; Bondt A; Wuhrer M; Standal T; Holst S
Biochim Biophys Acta Gen Subj; 2019 May; 1863(5):960-970. PubMed ID: 30844485
[TBL] [Abstract][Full Text] [Related]
5. IgD multiple myeloma: Clinical, biological features and prognostic value of the serum free light chain assay.
Djidjik R; Lounici Y; Chergeulaïne K; Berkouk Y; Mouhoub S; Chaib S; Belhani M; Ghaffor M
Pathol Biol (Paris); 2015 Sep; 63(4-5):210-4. PubMed ID: 26294067
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics and prognosis of immunoglobulin D myeloma in the novel agent era.
Chen L; Fan F; Deng J; Xu J; Xu A; Sun C; Hu Y
Ann Hematol; 2019 Apr; 98(4):963-970. PubMed ID: 30610280
[TBL] [Abstract][Full Text] [Related]
7. Capillary electrophoresis analysis of N-glycosylation changes of serum paraproteins in multiple myeloma.
Kovacs Z; Simon A; Szabo Z; Nagy Z; Varoczy L; Pal I; Csanky E; Guttman A
Electrophoresis; 2017 Sep; 38(17):2115-2123. PubMed ID: 28116769
[TBL] [Abstract][Full Text] [Related]
8. IgD-λ multiple myeloma with excessive excretion of free light chains: a diagnostic trap in the identification of monoclonal gammopathies.
Zahir H; Tali A; Rachidi M; Mouhib H; Daif H; Ait Ouzdi Z; Haouach K; Chabaa L
Ann Biol Clin (Paris); 2019 Feb; 77(1):107-111. PubMed ID: 30799291
[TBL] [Abstract][Full Text] [Related]
9. Serum N-glycan profiling as a diagnostic biomarker for the identification and assessment of psoriasis.
Zou C; Huang C; Yan L; Li X; Xing M; Li B; Gao C; Wang H
J Clin Lab Anal; 2021 Apr; 35(4):e23711. PubMed ID: 33507566
[TBL] [Abstract][Full Text] [Related]
10. Immunoglobulin D myeloma: clinical features and outcome in the era of novel agents.
Zagouri F; Kastritis E; Symeonidis AS; Giannakoulas N; Katodritou E; Delimpasi S; Repousis P; Terpos E; Dimopoulos MA;
Eur J Haematol; 2014 Apr; 92(4):308-12. PubMed ID: 24460646
[TBL] [Abstract][Full Text] [Related]
11. Immunoglobulin D myeloma--problems with diagnosing and staging (own experience and literature review).
Kuliszkiewicz-Janus M; Zimny A; Sokolska V; Saşiadek M; Kuliczkowski K
Leuk Lymphoma; 2005 Jul; 46(7):1029-37. PubMed ID: 16019554
[TBL] [Abstract][Full Text] [Related]
12. [Multiple myeloma with D immunoglobulin].
Benchekroun L; Ouzzif Z; Bouabdillah M; Jaouhar N; Aoufir F; Aoufi F; Chabraoui L
Ann Biol Clin (Paris); 2011; 69(5):581-7. PubMed ID: 22008139
[TBL] [Abstract][Full Text] [Related]
13. [Immunoglobulin D lambda multiple myeloma: a case report].
Qiao SK; Zhang XJ; Wang FX; Pan L; Yao L; Dong ZR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Jun; 15(3):643-6. PubMed ID: 17605885
[TBL] [Abstract][Full Text] [Related]
14. Characterization of IgG N-glycome profile in colorectal cancer progression by MALDI-TOF-MS.
Liu S; Cheng L; Fu Y; Liu BF; Liu X
J Proteomics; 2018 Jun; 181():225-237. PubMed ID: 29698801
[TBL] [Abstract][Full Text] [Related]
15. Polyclonal Immunoglobulin G N-Glycosylation in the Pathogenesis of Plasma Cell Disorders.
Mittermayr S; Lê GN; Clarke C; Millán Martín S; Larkin AM; O'Gorman P; Bones J
J Proteome Res; 2017 Feb; 16(2):748-762. PubMed ID: 27936757
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and outcome of allogeneic transplantation in IgD and nonsecretory myeloma. A report on behalf of the Myeloma Subcommittee of the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation.
Morris C; Iacobelli S; Gahrton G; van Biezen A; Drake M; Garderet L; Potter M; Schattenberg AV; Cornelissen JJ; Hamladji RM; Martelli M; Petersen E; Rovira M; Bandini G; Kroger N; de Witte T
Biol Blood Marrow Transplant; 2015 Jun; 21(6):1054-8. PubMed ID: 25708221
[TBL] [Abstract][Full Text] [Related]
17. A case of IgD myeloma representing a missed biclonal paraproteinemia or isotype switch in a patient previously diagnosed with IgA-lambda myeloma.
Chepovetsky J; Chari A; Jagannath S; Ramanthan L
Clin Chim Acta; 2013 Oct; 425():233-5. PubMed ID: 23954772
[TBL] [Abstract][Full Text] [Related]
18. Isomer-specific profiling of N-glycans derived from human serum for potential biomarker discovery in pancreatic cancer.
Liu Y; Wang C; Wang R; Wu Y; Zhang L; Liu BF; Cheng L; Liu X
J Proteomics; 2018 Jun; 181():160-169. PubMed ID: 29674015
[TBL] [Abstract][Full Text] [Related]
19. Detection of intracellular IgD using flow cytometry could be a novel and supplementary method to diagnose IgD multiple myeloma.
Wang W; Zhang CX; Li ZL; Gong M; Ma YG
BMC Cancer; 2018 Jun; 18(1):650. PubMed ID: 29890944
[TBL] [Abstract][Full Text] [Related]
20. Unusually prominent M protein in Indian patients with IgD multiple myeloma.
Inamdar NA; Parikh PM; Hedge RM; Karkhanis VC; Sastry PS; Gopal R; Raste AS; Advani SH
Acta Haematol; 1995; 94(4):216-7. PubMed ID: 8610482
[No Abstract] [Full Text] [Related]
[Next] [New Search]
